Home
Cellectis
Home
FAQ
Job opportunites
Site map
Contact
Location
Search
Home > Shareholders

Shareholders

CELLECTIS' main shareholders are a group of venture capital investors who hold around 52.5% of the company's shares. The Institut Pasteur holds 5.5% and the balance (around 41%) is held by the public (23%) and a number of individuals linked to the company, including its managers and staff (19%).

Annual General Meeting

Cellectis' Annual General Meeting is due to take place on May 27 2008 at the Biocitech site.

Documentation concerning the AGM will be available on site or from the company on request.

Archives

CELLECTIS SA
RATIONAL GENOME ENGINEERING

Parc Biocitech 102 avenue Gaston Roussel - F-93235 Romainville Cedex
Tel.: +33 1 41 83 99 00 - Fax: +33 1 41 83 99 03
Last Update 03/07/2008 Legal Notice
Version Française